Skip to main content

#156409

R-3327-MAT-Lu cell line

Cat. #156409

R-3327-MAT-Lu cell line

Cat. #: 156409

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Disease: Cancer

Model: Cancer Model

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: John Isaacs

Institute: Johns Hopkins University

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: R-3327-MAT-Lu cell line
  • Cancer: Genitourinary cancer
  • Cancers detailed: Prostate
  • Research fields: Cancer;Drug development
  • Disease: Cancer
  • Model: Cancer Model
  • Description: This cell line was derived from the "H" subline and upon passage to the AT-1 subline (JHU-29) of the parental R3327 tumor. The "H" subline is a heterogeneous cell line as it is comprised of androgen-dependent and androgen-independent tumor cells. Passing this AT-1 sublinein intactmale rats allowed for the cloning of androgen-independent cell lines which gave rise to a fast-growing metastatic, anaplastic tumor (MAT) cell line which was further characterized to be highly metastatic to the lung (MAT-Lu). This cell line is a valuable model for the studying prostate malignancies both in vitro, and in vivo.DM 3852
  • Cellosaurus id: CVCL_3847

Target Details

  • Target: Metastatic anaplastic tumor that is highly metastatic in the lung

Handling

  • Format: Frozen
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Isaacs et al. 1988. Prostate. 13(2):165-88. PMID: 3174494.
  • Isaacs et al. 1986. Prostate. 9(3):261-81. PMID: 3774632.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.